array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(24) "Idexx Laboratories, Inc."
["slug"]=>
string(31) "52dfe-us-idexx-laboratories-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/adce9a3c-023b-4043-9c56-fbed7dab6f62"
["description"]=>
string(1658) "10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock
We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.
Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices.
We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk.
Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities."
["address_street"]=>
string(10) "1 Idexx Dr"
["address_place"]=>
string(9) "Westbrook"
["address_region"]=>
string(5) "Maine"
["founding_date"]=>
string(10) "1983-02-28"
["website_domain"]=>
string(9) "idexx.com"
["website_url"]=>
string(21) "https://www.idexx.com"
["industry_codes"]=>
array(4) {
[0]=>
string(43) "General Livestock, Except Dairy and Poultry"
[1]=>
string(33) "Veterinary Services for Livestock"
[2]=>
string(27) "Pharmaceutical Preparations"
[3]=>
string(42) "In Vitro and In Vivo Diagnostic Substances"
}
["employee_count"]=>
int(710)
["article_count"]=>
int(644)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(66) "IDEXX Laboratories to Release 2024 First Quarter Financial Results"
["snippet_en"]=>
string(233) "WESTBROOK, Maine, April 04, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens."
["url"]=>
string(90) "https://es-us.finanzas.yahoo.com/news/idexx-laboratories-release-2024-first-203000755.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/05f95f58-f430-4b50-a78f-c08f08e16130"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2024-04-04"
["categories"]=>
array(3) {
[0]=>
string(14) "Product Launch"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(24) "Quarterly/Annual Figures"
}
}
[1]=>
array(7) {
["title_en"]=>
string(112) "Veterinary Radiology Software Market Analysis and Revenue Prediction | VetZ GmbH, IDEXX, Paxeramed Corp - Amoré"
["snippet_en"]=>
string(112) "Veterinary Radiology Software Market Analysis and Revenue Prediction | VetZ GmbH, IDEXX, Paxeramed Corp - Amoré"
["url"]=>
string(129) "http://amore.ng/worldwide/23/veterinary-radiology-software-market-analysis-and-revenue-prediction-vetz-gmbh-idexx-paxeramed-corp/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/c1652210-6a2e-44fe-a1b7-3505e4cb3ed7"
["source"]=>
string(8) "amore.ng"
["publication_date"]=>
string(10) "2024-03-21"
["categories"]=>
array(1) {
[0]=>
string(31) "Financial Update/Profit Warning"
}
}
[2]=>
array(7) {
["title_en"]=>
string(56) "IDEXX (IDXX) Q4 Earnings Surpass Estimates, Margins Fall"
["snippet_en"]=>
string(92) "Across testing modalities, IDEXX (IDXX) achieves strong global growth in the fourth quarter."
["url"]=>
string(76) "https://finance.yahoo.com/news/idexx-idxx-q4-earnings-surpass-153700324.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/501a77ec-40e7-4519-b7de-bbac31936f0e"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2024-02-05"
["categories"]=>
array(2) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(31) "Financial Update/Profit Warning"
}
}
[3]=>
array(7) {
["title_en"]=>
string(53) "New York: new bullish momentum for IDEXX Laboratories"
["snippet_en"]=>
string(144) "Marked increase for the world leader in the development of laboratory services and tests for animals, with a profit of 1.93% on previous values."
["url"]=>
string(115) "https://www.teleborsa.it/News/2024/01/09/new-york-nuovo-spunto-rialzista-per-idexx-laboratories-249_TLB-1LINER.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/14570ac3-7dbf-48f4-895d-5a115d629197"
["source"]=>
string(12) "teleborsa.it"
["publication_date"]=>
string(10) "2024-01-09"
["categories"]=>
array(4) {
[0]=>
string(14) "Product Launch"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(18) "Expansion & Growth"
[3]=>
string(5) "R & D"
}
}
[4]=>
array(7) {
["title_en"]=>
string(48) "New York: positive result for IDEXX Laboratories"
["snippet_en"]=>
string(148) "Marked increase for the world leader in the development of laboratory services and tests for animals, which makes a profit of 1.93% on the values..."
["url"]=>
string(126) "https://finanza.lastampa.it/News/2024/01/09/new-york-risultato-positivo-per-idexx-laboratories/MTkxXzIwMjQtMDEtMDlfVExCLUFVVE8"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1fdaeabb-1f4e-4f94-807b-0ff6b72b7e03"
["source"]=>
string(11) "lastampa.it"
["publication_date"]=>
string(10) "2023-12-04"
["categories"]=>
array(4) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(18) "Ecological Impacts"
[3]=>
string(5) "R & D"
}
}
[5]=>
array(7) {
["title_en"]=>
string(55) "IDEXX Laboratories (IDXX) Fell on Investors’ Concerns"
["snippet_en"]=>
string(255) "Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The market rally that was driven by technology this year came to a halt in the third quarter."
["url"]=>
string(87) "https://hk.finance.yahoo.com/news/idexx-laboratories-idxx-fell-investors-170025554.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/a3643510-4bce-4d86-9855-511dd1522e43"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-11-11"
["categories"]=>
array(6) {
[0]=>
string(9) "Investors"
[1]=>
string(18) "General Investment"
[2]=>
string(24) "Quarterly/Annual Figures"
[3]=>
string(31) "Financial Update/Profit Warning"
[4]=>
string(15) "Market Movement"
[5]=>
string(12) "Stock Market"
}
}
[6]=>
array(7) {
["title_en"]=>
string(55) "IDEXX Laboratories (IDXX) Fell on Investors’ Concerns"
["snippet_en"]=>
string(255) "Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The market rally that was driven by technology this year came to a halt in the third quarter."
["url"]=>
string(84) "https://finance.yahoo.com/news/idexx-laboratories-idxx-fell-investors-170025554.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/0cb4817a-d90d-4134-9e8e-4cbc7b5de8f3"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-11-11"
["categories"]=>
array(6) {
[0]=>
string(9) "Investors"
[1]=>
string(18) "General Investment"
[2]=>
string(24) "Quarterly/Annual Figures"
[3]=>
string(31) "Financial Update/Profit Warning"
[4]=>
string(15) "Market Movement"
[5]=>
string(12) "Stock Market"
}
}
[7]=>
array(7) {
["title_en"]=>
string(72) "Idexx 3Q Net Income Rises Sharply on Rising Demand for Vet Tech Products"
["snippet_en"]=>
string(157) "By Rob Curran Idexx Laboratories posted 17% growth in third-quarter net income as the pet boom that began during the pandemic continued, and veterinarians..."
["url"]=>
string(115) "https://www.marketwatch.com/story/idexx-3q-net-income-rises-sharply-on-rising-demand-for-vet-tech-products-780b5a6e"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/97e854c6-4da3-459a-880c-0986e3b34f11"
["source"]=>
string(15) "marketwatch.com"
["publication_date"]=>
string(10) "2023-11-01"
["categories"]=>
array(4) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(8) "Epidemic"
[3]=>
string(19) "Economic Conditions"
}
}
[8]=>
array(7) {
["title_en"]=>
string(67) "IDEXX Labs Lifts FY23 Earnings View, Cuts Revenue Forecast - Update"
["snippet_en"]=>
string(226) "IDEXX Laboratories Inc (IDXX), while reporting higher third-quarter results, on Wednesday raised its fiscal 2023 earnings view, but trimmed revenue forecast.For the full year, the company now expects earnings in a range of $9."
["url"]=>
string(101) "https://www.rttnews.com/3401408/idexx-labs-lifts-fy23-earnings-view-cuts-revenue-forecast-update.aspx"
["image_url"]=>
NULL
["source"]=>
string(11) "rttnews.com"
["publication_date"]=>
string(10) "2023-11-01"
["categories"]=>
array(4) {
[0]=>
string(24) "Quarterly/Annual Figures"
[1]=>
string(31) "Financial Update/Profit Warning"
[2]=>
string(12) "Stock Market"
[3]=>
string(25) "Business Model Resilience"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(117)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(67)
}
[2]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(44)
}
[3]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(43)
}
[4]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(40)
}
[5]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(24)
}
[6]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(22)
}
[7]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(22)
}
[8]=>
array(2) {
["name"]=>
string(12) "Restatements"
["count"]=>
int(21)
}
[9]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(19)
}
[10]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(18)
}
[11]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(16)
}
[12]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(14)
}
[13]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(12)
}
[14]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(9)
}
[15]=>
array(2) {
["name"]=>
string(9) "Investors"
["count"]=>
int(9)
}
[16]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(8)
}
[17]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(8)
}
[18]=>
array(2) {
["name"]=>
string(31) "Water and Wastewater Management"
["count"]=>
int(7)
}
[19]=>
array(2) {
["name"]=>
string(16) "Share Repurchase"
["count"]=>
int(7)
}
[20]=>
array(2) {
["name"]=>
string(25) "Business Model Resilience"
["count"]=>
int(7)
}
[21]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(7)
}
[22]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(7)
}
[23]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(6)
}
[24]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(6)
}
[25]=>
array(2) {
["name"]=>
string(15) "Blogs & Columns"
["count"]=>
int(6)
}
[26]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(5)
}
[27]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(5)
}
[28]=>
array(2) {
["name"]=>
string(20) "Corporate Governance"
["count"]=>
int(5)
}
[29]=>
array(2) {
["name"]=>
string(12) "Going Public"
["count"]=>
int(5)
}
}
}
52dfe-us-idexx-laboratories-inc
Idexx Laboratories, Inc.
Location
Maine
Founded
1983-02-28
Website
https://www.idexx.com
Articles
644 Articles
Category
General Livestock, Except Dairy and Poultry
Veterinary Services for Livestock
Pharmaceutical Preparations
In Vitro and In Vivo Diagnostic Substances
Description
10,000 people, one global focus - enhancing the health and well-being of pets, people, and livestock
We are passionate about what we do at IDEXX – and why wouldn’t we be? When you’re working to raise the standard of care for pets, make drinking water safe for billions and keep our livestock population around the globe healthy and free of disease, it’s no wonder that what we do each day is more than just a job. There’s an energy across IDEXX that is contagious – where caring and committed people come together to make things better.
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a member of the S&P 500, is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. Headquartered in southern Maine, we conduct operations through more than 70 locations around the world and serve customers in over 175 countries.
Our primary business focuses on pet health, a growing market around the world. Our products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices.
We also develop and manufacture diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water and milk.
Please visit our website, IDEXX.com/careers, for further information and to view all of our job opportunities.
WESTBROOK, Maine, April 04, 2024--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2024 first quarter results for Wednesday, May 1, 2024, before the market opens.
Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The market rally that was driven by technology this year came to a halt in the third quarter.
Baron Funds, an investment management company, released its “Baron Asset Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here. The market rally that was driven by technology this year came to a halt in the third quarter.
By Rob Curran Idexx Laboratories posted 17% growth in third-quarter net income as the pet boom that began during the pandemic continued, and veterinarians...
IDEXX Laboratories Inc (IDXX), while reporting higher third-quarter results, on Wednesday raised its fiscal 2023 earnings view, but trimmed revenue forecast.For the full year, the company now expects earnings in a range of $9.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.